CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 710 enrolled
Drug / intervention
Ibuprofen +4 moredrug
Likely dose
Ibuprofen 10mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03767933
NCT03767933Phase 2Completed

A Study of Non-Steroidal or Opioid Analgesia Use for Children With Musculoskeletal Injuries: The No OUCH Trials

University of Alberta·interventional·Posted Dec 7, 2018·Updated Sep 19, 2024

In Brief

A Phase 2 clinical trial evaluating Ibuprofen, Acetaminophen, and 3 other interventions for Musculoskeletal Injury. Completed, enrolled 710 participants across 6 sites.

Detailed Summary

Musculoskeletal (MSK) injuries, including limb injuries, are the most common cause for Emergency Department (ED) visits for children with pain. Broken arms and legs are known to cause moderate to severe pain in most children, yet previous research shows that children's pain in the emergency department is still under-treated. Further, children are less likely to receive appropriate pain medicine than adults with similar injuries. The purpose of this research study is to compare the effectiveness and safety of 3 different possible medication combinations, for the pain management of children with acute MSK limb injuries. The pain medicines the investigators are studying are ibuprofen (Advil/Motrin), acetaminophen (Tylenol/Tempra), and hydromorphone (Dilaudid). This study will consist of 2 trials that will be run simultaneously. Eligible caregiver/ child pairs presenting to the emergency department with acute MSK limb injury will decide in which trial they wish to participate: the Opioid trial or the Non-Opioid trial. If they select the Non-opioid trial, they will have an equal chance of receiving either (a) Ibuprofen OR (b) Ibuprofen and acetaminophen. If they select the Opioid trial, they will have an equal chance of receiving either (a) Ibuprofen OR (b) Ibuprofen and acetaminophen OR (c) Ibuprofen and hydromorphone. Regardless of which study they choose, their child will, at minimum, receive Ibuprofen (Advil/Motrin) for their pain. All study medicines will be given in oral liquid form. This study will help the investigators figure out which pain medicine or combination of pain medicines works best for children with limb injuries. Promotion of adequate acute pain treatment of children presenting to the ED may help prevent the known short and long-term effects of inadequately treated pain in children, including unpleasant memories, stress and anxiety upon future visits to healthcare, and compromised functional outcomes such as missed school.

Study Details

Timeline

Phase 2CompletedFinished
20192020202120222023202420252026
First PostedDec 7, 2018
Enrollment StartApr 20, 2019
Primary CompletionMar 9, 2023
Study CompletionMar 22, 2023
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 7.6 years ago

Interventions

Ibuprofendrug

10mg/kg, maximum 600mg; Oral liquid

Acetaminophendrug

15mg/kg, maximum 1000mg; Oral liquid

Hydromorphonedrug

0.05mg/kg, maximum 5 mg; Oral liquid

Acetaminophen placebodrug

Oral liquid

Hydromorphone placebodrug

Oral liquid